These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 34321771)

  • 21. Mixed low- and high-grade papillary urothelial carcinoma: histopathogenetic and clinical significance.
    Mai KT; Flood TA; Williams P; Kos Z; Belanger EC
    Virchows Arch; 2013 Oct; 463(4):575-81. PubMed ID: 23913166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytopathologic differential diagnosis of low-grade urothelial carcinoma and reactive urothelial proliferation in bladder washings: a logistic regression analysis.
    Cakir E; Kucuk U; Pala EE; Sezer O; Ekin RG; Cakmak O
    APMIS; 2017 May; 125(5):431-436. PubMed ID: 28225151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urinary tract cytology: a cytologic-histopathologic correlation with The Paris System, an institutional study.
    Danakas A; Sweeney M; Cheris S; Agrawal T
    J Am Soc Cytopathol; 2021; 10(1):56-63. PubMed ID: 33132054
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urinary tract washing specimens containing atypical urothelial tissue fragments are significantly associated with urothelial neoplasia.
    Zhang ML; Zhou AG; Rosenthal DL; VandenBussche CJ
    Diagn Cytopathol; 2017 Sep; 45(9):795-799. PubMed ID: 28597510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subclassifying atypia in urine cytology: what are the helpful features?
    McCroskey Z; Bahar B; Hu Z; Wojcik EM; Barkan GA
    J Am Soc Cytopathol; 2015; 4(4):183-189. PubMed ID: 31051752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Digital image analysis supports a nuclear-to-cytoplasmic ratio cutoff value below 0.7 for positive for high-grade urothelial carcinoma and suspicious for high-grade urothelial carcinoma in urine cytology specimens.
    McIntire PJ; Snow JT; Elsoukkary SS; Soong L; Sweeney J; Robinson BD; Siddiqui MT
    Cancer Cytopathol; 2019 Feb; 127(2):120-124. PubMed ID: 30395388
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Significance of a minor high-grade component in a low-grade noninvasive papillary urothelial carcinoma of bladder.
    Reis LO; Taheri D; Chaux A; Guner G; Mendoza Rodriguez MA; Bivalacqua TJ; Schoenberg MP; Epstein JI; Netto GJ
    Hum Pathol; 2016 Jan; 47(1):20-5. PubMed ID: 26520419
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The predictive value of positive and suspicious urine cytology: Are they different?
    Kuan KC; Segura SE; Ahlstedt J; Khader SN; Hakima L
    Diagn Cytopathol; 2020 Nov; 48(11):998-1002. PubMed ID: 32558388
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyto-histo correlations of plasmacytoid and micropapillary variants of high-grade urothelial carcinoma: do they fit well in The Paris System for reporting urinary cytology?
    Suo L; Vega I; Thrall M
    J Am Soc Cytopathol; 2021; 10(1):20-24. PubMed ID: 32620533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Negative predictive value and sensitivity of urine cytology prior to implementation of The Paris System for Reporting Urinary Cytology.
    McIntire PJ; Khan R; Hussain H; Pambuccian SE; Wojcik EM; Barkan GA
    Cancer Cytopathol; 2019 Feb; 127(2):125-131. PubMed ID: 30668891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytohistological correlation of urine cytology in a tertiary centre with application of the Paris system.
    Rohilla M; Singh P; Rajwanshi A; Gupta N; Srinivasan R; Dey P; Kakkar N
    Cytopathology; 2018 Oct; 29(5):436-443. PubMed ID: 29920811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of the Paris system for reporting urinary cytology with histologic follow-up.
    Rohra P; Ocampo Gonzalez FA; Yan L; Mir F; Furlan K; Basu S; Barua A; Cheng L; Park JW
    Diagn Cytopathol; 2021 Jun; 49(6):691-699. PubMed ID: 33600080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p16/Ki-67 dual labeling and urinary cytology results according to the New Paris System for Reporting Urinary Cytology: Impact of extended follow-up.
    Piaton E; Advenier AS; Carré C; Decaussin-Petrucci M; Mège-Lechevallier F; Hutin K; Nennig C; Colombel M; Ruffion A
    Cancer Cytopathol; 2017 Jul; 125(7):552-562. PubMed ID: 28371465
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The combination cytology/epichek test in non muscle invasive bladder carcinoma follow-up: Effective tool or useless expence?
    Pierconti F; Martini M; Fiorentino V; Cenci T; Capodimonti S; Straccia P; Sacco E; Pugliese D; Cindolo L; Larocca LM; Bassi PF
    Urol Oncol; 2021 Feb; 39(2):131.e17-131.e21. PubMed ID: 32773233
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypochromatic large urothelial cells in urine cytology are indicative of high grade urothelial carcinoma.
    Pierconti F; Martini M; Straccia P; Fiorentino V; Musarra T; Larocca LM; Lopez-Beltran A
    APMIS; 2018 Sep; 126(9):705-709. PubMed ID: 30160022
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Paris System "atypical urothelial cells" category: can the current criteria be improved?
    Vosoughi A; Ordobazari A; Lora Gonzalez MA; Guido LP; Skiba M; Campuzano-Zuluaga G; Kryvenko ON; Gomez-Fernandez C; Garcia-Buitrago M; Jorda M
    J Am Soc Cytopathol; 2021; 10(1):3-8. PubMed ID: 32732113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Utility of The Paris System for Reporting Urinary Cytology in patients with HPV-positive urinary tract carcinoma.
    Tanaka K; Kayraklioglu N; Chan E; Ding CC; Vohra P
    Cancer Cytopathol; 2024 Oct; ():. PubMed ID: 39403894
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new 7-point method facilitates accurate diagnosis of high-grade urothelial carcinoma in routine urinary cytology practice.
    Iwai S; Mimura A; Ohtani H; Shimokama T; Kinjo M
    J Am Soc Cytopathol; 2021; 10(1):103-109. PubMed ID: 33092994
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Utility of Image Morphometry in the Atypical Urothelial Cells and High-Grade Urothelial Carcinoma Categories of the Paris System for Reporting Urinary Cytology.
    Sharan KC; Rohilla M; Dey P; Srinivasan R; Kakkar N; Mavuduru RS
    J Cytol; 2024; 41(3):137-142. PubMed ID: 39239321
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic Immunocytostaining with Peroxisome Proliferator-Activated Receptor-Gamma in Urine Cytology Samples.
    Tanaka S; Tokuhara Y; Ariyasu S; Morinishi T; Yamamoto T; Teramoto N; Hirakawa E
    Acta Cytol; 2024; 68(1):60-65. PubMed ID: 38008063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.